As of 2024-12-13, the Intrinsic Value of Neurocrine Biosciences Inc (NBIX) is
48.66 USD. This NBIX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 126.79 USD, the upside of Neurocrine Biosciences Inc is
-61.60%.
The range of the Intrinsic Value is 34.18 - 92.94 USD
48.66 USD
Intrinsic Value
NBIX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
34.18 - 92.94 |
48.66 |
-61.6% |
| DCF (Growth 10y) |
54.55 - 148.72 |
77.87 |
-38.6% |
| DCF (EBITDA 5y) |
68.92 - 81.58 |
72.45 |
-42.9% |
| DCF (EBITDA 10y) |
86.07 - 109.35 |
94.00 |
-25.9% |
| Fair Value |
95.28 - 95.28 |
95.28 |
-24.85% |
| P/E |
69.26 - 124.86 |
95.98 |
-24.3% |
| EV/EBITDA |
63.08 - 113.05 |
93.87 |
-26.0% |
| EPV |
26.38 - 33.08 |
29.73 |
-76.6% |
| DDM - Stable |
44.02 - 170.96 |
107.49 |
-15.2% |
| DDM - Multi |
58.10 - 174.75 |
87.13 |
-31.3% |
NBIX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
12,837.49 |
| Beta |
0.59 |
| Outstanding shares (mil) |
101.25 |
| Enterprise Value (mil) |
12,488.39 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.03% |
| Cost of Debt |
4.25% |
| WACC |
7.97% |